Borgen discusses Christopher v. SmithKline Beecham ruling

October 1, 2012

GBDH Partner David Borgen discusses U.S. Supreme Court’s June ruling in Christopher v. SmithKline Beecham Corp. d/b/a Glaxo-SmithKline that pharmaceutical sales reps were ineligible for overtime pay under the FLSA’s “outside salesman” exemption.

Read the Article